Technology | February 13, 2013

Nuclear Medicine Information Systems and BioDose Rebrand, Relaunch Nuclear Image Dose Management Solution

February 13, 2013 — Nuclear Medicine Information Systems LLC (NMIS) and BioDose LLC have been renamed and rebranded as ec2 Software Solutions, company officials announced.

Somerset, N.J.-based NMIS was established in 1985 to help hospital and nuclear pharmacy administrators manage record keeping for nuclear medicine departments in hospitals and medical clinics specializing in nuclear medicine services. BioDose, based out of Las Vegas, was a 1999 spin-off positioned to help nuclear medicine teams implement and manage software needs in the nuclear medicine industry.

Today, the two companies offer industry-leading software solutions that help medical providers navigate the vast and complex administration and regulations of the nuclear medicine industry. The company has approximately 5,500 customers worldwide in hospitals, nuclear pharmacies and out-patient facilities.

"As our two companies evolved, it became clear to us that we needed a unified brand and identity," said CEO Scott Nelson. "We feel that ec2 Software Solutions is a much better way for us to be seen and understood by current and future customers. This rebrand takes our company to a new level."

The company's software also helps facilities move from paper-based environments to fully-electronic document management systems. Doses, histories, batch records and complete regulatory compliance are accurately managed with ec2's suite of software solutions. Many software options are available and are customized to meet individual needs.

In addition to a new name, ec2 Software Solutions' rebrand includes a new logo and supporting marketing materials. A new website is also being launched in the spring.

"Throughout the years, we have listened to our customers and developed comprehensive solutions for all of their needs," added Nelson. "As the industry continues to evolve, our technology and software solutions will continue to exceed customer need and expectation."

For more information: www.ec2software.com

Related Content

PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
Nuclear imaging scan showing very good tissue delineation. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Nuclear imaging scan showing very good tissue delineation. It offers crisp overall image quality and sharply delineates the muscle and fat planes, vertebral margins and end plates, billiary radicals, renal calyces, aortic wall and papillary muscles of the heart. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Technology | PET-CT | June 05, 2018
June 5, 2018 — The U.S.
Emerging Trends in Nuclear Medicine
Feature | Nuclear Imaging | June 04, 2018 | By Jeff Zagoudis
Nuclear imaging and its various modalities have long played an important role in the diagnosis and treatment of numer
Latest additions to Somatom go. CT platform address advanced clinical fields and applications, including cardiology, CT-guided intervention and dual energy CT. How to lower radiation dose from Computed tomography scanners using ned technology.

Latest additions to Somatom go. CT platform address advanced clinical fields and applications, including cardiology, CT-guided intervention and dual energy CT.

Feature | Computed Tomography (CT) | June 04, 2018 | By Melinda Taschetta-Millane
Recent studies show a rapid increase in patient radiation exposure mainly due to increased use of medical imaging, pa
News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...
PET Imaging Agent Could Provide Early Diagnosis of Rheumatoid Arthritis

Coronal 18F-FEDAC PET/CT section of a mouse with collagen-induced arthritis. (A) On day 23 and day 37, increased uptake is noted in the front and hind paws of this mouse with collagen-induced arthritis. (B) Predictive performance of day 23 18F-FEDAC uptake for the development of clinical arthritis. ROC = receiver operating characteristic; Sn = sensitivity; Sp = specificity. Credit: Seoul National University and Ewha Womans University, Seoul, South Korea

News | PET Imaging | May 17, 2018
A novel positron emission tomography (PET) tracer developed by Korean researchers can visualize joint inflammation and...
PET Imaging Shows Protein Clumping May Contribute to Heart Failure Development
News | PET Imaging | May 11, 2018
A team led by Johns Hopkins University Researchers has discovered that protein clumps appear to accumulate in the...
Samsung Adds S-Vue 3.02 Imaging Engine to GC85A Digital X-ray for Lower Dose
News | Digital Radiography (DR) | May 10, 2018
As part of a growth vision centered on improving patient care quality and safety, Samsung has incorporated the S-Vue 3....
News | Radiopharmaceuticals and Tracers | May 09, 2018
Blue Earth Diagnostics signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a specialist in...
Overlay Init